Crinetics Pharmaceuticals Q4 EPS $(0.68) Down From $(0.66) YoY

Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(0.68) per share. This is a 3.03 percent decrease over losses of $(0.66) per share from the same period last year.

Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(0.68) per share. This is a 3.03 percent decrease over losses of $(0.66) per share from the same period last year.

Total
0
Shares
Related Posts